Mini-audit: Pancreatic exocrine insufficiency (PEI)

Activity aim

In this mini-audit you will conduct a review of patients with pancreatic exocrine insufficiency (PEI) who are currently receiving PERT (pancreatic enzyme replacement therapy), in order to assess their quality of life and treatment effectiveness, and optimise their therapy.

Why take part in this program?

• Evaluate PERT dosing and treatment adherence in 3 patients in line with current Australian and UK Guidelines and develop future management plans informed by best practice.
• You will need to identify at least one actual patient; fictional case studies are provided for two additional patients if required.
• Earn 4.5 CPD hours on completion.

Learning outcomes

• Identify at least one patient 18 years or older in your practice diagnosed with PEI and currently undergoing PERT who require management review
• Assess whether patients’ PEI symptoms are adequately/not adequately controlled
• Screen for identifiable issues related to treatment adherence and behaviours when taking PERT
• Develop a management plan to adjust PERT dosing if needed, and to address treatment adherence/behaviour issues.

Inclusion criteria

Patients who are eligible for this audit include:

• Adults diagnosed with PEI and currently undergoing PERT
• Patients who have been taking PERT an adequate amount of time since initiation or previous review to identify impacts of initiation or review.

How long should it take?

The time taken to complete this mini-audit will depend on the number of eligible patients in your practice. It can be done with 1-3 actual patients, with fictional case studies provided if you cannot identify three patients.

Tips to recruit patients

Recruitment may occur:

• Opportunistically as you review appropriate patients as part of usual care.
• By active recall.

This activity is sponsored by Viatris.